0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

PatientMetRx a new AI driven social intelligence service launches today
February 4, 2021
PatientMetRx

 Talking Medicines is the world’s first social intelligence company designed specifically for the pharmaceutical industry: PatientMetrx

By structuring and translating the patient’s voice on social media into actionable intelligence, it focuses on assisting pharmaceutical companies deliver a greater return on investment for marketing and deliver better health outcomes for patients.

Talking Medicines has today launched PatientMetRx, its artificial intelligence (“AI”) and natural language processing (“NLP”) powered social intelligence service to provide pharmaceutical companies with insights on patient experience on a scale and depth not previously possible.

Powered by Eva, a proprietary AI machine developed by Talking Medicines, PatientMetRx combines machine learning and natural language processing to capture the voice of the patient from millions of conversations taking place over multiple sources including social media, forums and blogs, mapped to a curated database of 130,000 regulated global medicines.  It distils what patients are saying online, and what they are feeling, into powerful data insights to provide pharmaceutical companies with a systematic way of measuring patient experience towards medicines.

Talking Medicines will sell PatientMetRx on a subscription basis to clients.  Delivered on a digital dashboard, PatientMetRx provides pharmaceutical companies with a ‘Patient Confidence Score’ to benchmark each medicine, offering a systematic way of understanding trending patient confidence in their drug brands.  Tracking this Patient Confidence Score enables them to more accurately measure the effectiveness of marketing campaigns, reduce budgets, improve market competitiveness and deliver better health outcomes for patients.

The team are delighted to bring this innovation to market, more can be found at https://www.patientmetrx.com 

 

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...